Results 191 to 200 of about 12,716,621 (343)
Architect Insights: Implications and Barriers of Future-Proofing Hospitals. [PDF]
Memari S +4 more
europepmc +1 more source
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad +35 more
wiley +1 more source
Does tobacco use influence bone mineral density levels in a Norwegian youth cohort followed from adolescence to young adulthood? The Fit Futures Study (2010-2022). [PDF]
Sagelv EH +8 more
europepmc +1 more source
Design Beyond Design Thinking: Designing Postdigital Futures when Weaving Worlds with Others
Felicitas Macgilchrist +3 more
semanticscholar +1 more source
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola +12 more
wiley +1 more source
Generative AI for navigating synthesizable chemical space. [PDF]
Gao W, Luo S, Coley CW.
europepmc +1 more source
Desirable futures: Human-nature relationships in urban planning and design
Fabiano Lemes de Oliveira +1 more
semanticscholar +1 more source
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg +43 more
wiley +1 more source
Unexplored dimension of shift work: the effects of late-early shifts on nurses and their wellbeing - a qualitative study. [PDF]
Karki U, Dafny HA.
europepmc +1 more source
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source

